Featured
Framatome and Korea Hydro & Nuclear Power (KHNP) have signed a memorandum of understanding (MoU) to demonstrate the feasibility of producing non-carrier added lutetium-177, a medical isotope used for a […]
Framatome and Korea Hydro & Nuclear Power (KHNP) have signed a memorandum of understanding (MoU) to demonstrate the feasibility of producing non-carrier added lutetium-177, a medical isotope used for a […]